FDA Clearance Tracker · K233200
XPLUS 35 Series (XPLUS 35, XPLUS 35FD)
Last checked: Nov 19, 2026Latest source record: Nov 16, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Nov 16, 2023
Substantially Equivalent
Time to decision
49 days
Received Sep 28, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K233200
- Device name
- XPLUS 35 Series (XPLUS 35, XPLUS 35FD)
- Applicant
- GEMSS HEALTHCARE CO., LTD.
- Applicant location
- Paju-Si, KR
- Received
- Sep 28, 2023
- Decided
- Nov 16, 2023
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 892.1650
- Specialty
- Radiology & Imaging
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code OWB. The earliest in FDA's data is K912448, decided Aug 28, 1991.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K233200
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for GEMSS HEALTHCARE CO., LTD.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- XLITEThird-party review510(k)
K260236 · Decided Aug 3, 2026 · 189 days after receipt
Device type: System, X-Ray, Mobile (IZL) · Radiology & Imaging
K230800 · Decided Nov 2, 2023 · 224 days after receipt
Device type: System, X-Ray, Stationary (KPR) · Radiology & Imaging
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.